KEPIVANCE
Live / Registered — Registered and renewed (as of 13 Mar 2026)
What this means for you
Registered since 24 Jan 2006. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 24 Jan 2026).
Record
- Serial number
- 78493232
- Registration number
- 3049649
- Mark type
- Stylized text
- Filed
- 01 Oct 2004
- Published for opposition
- 01 Nov 2005
- Registered
- 24 Jan 2006
- Next maintenance due
- 24 Jan 2026
- Attorney of record
- B. BRETT HEAVNER
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations used for the treatment of injury to epithelial cells and tissues
Owner
- SWEDISH ORPHAN BIOVITRUM AB (PUBL), Stockholm, SE
- BIOVITRUM AB (PUBL), STOCKHOLM, SE
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 13 Mar 2026 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 13 Mar 2026 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 13 Mar 2026 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 13 Mar 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Dec 2025 — TEAS SECTION 8 & 9 RECEIVED
- 24 Jan 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 19 Mar 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 19 Mar 2016 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 19 Mar 2016 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 19 Mar 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 12 Jan 2016 — TEAS SECTION 8 & 9 RECEIVED
- 12 Mar 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
- 09 Mar 2012 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 09 Mar 2012 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 23 Jan 2012 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED